Century Therapeutics Inc
NASDAQ:IPSC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Century Therapeutics Inc
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
260.3m USD | 49.8 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
297.7B USD | 6.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
160.2B USD | 7.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.2B USD | 11.2 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
114.2B USD | 8.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
139.1B AUD | 7.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
81.1B USD | 3.6 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
53.6B USD | 8.9 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.2 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.7B USD | 4 | |
| KR |
|
Celltrion Inc
KRX:068270
|
38T KRW | 16.8 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
You don't have any saved screeners yet
